Evangelia Pantazaka

7PUBLICATIONS
23CO-AUTHORS
Molecular targetsPredictive and prognostic markersOral implantologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 03, 2026
Repurposing Artesunate to Combat Progression and Metastasis via Targeting Circulating Tumor Cells.

|Feb 18, 2026
Metabolic marker profiling of circulating tumour cells in NSCLC patients treated with osimertinib: focus on MCT1 and MCT4.

Karolina Mangani, Evangelia Pantazaka, Evi Lianidou

|Apr 26, 2024
Current Progress and Future Perspectives in Contact and Releasing-Type Antimicrobial Coatings of Orthopaedic Implants: A Systematic Review Analysis Emanated from In Vitro and In Vivo Models.

Angelos Kaspiris, Elias Vasiliadis, Evangelia Pantazaka

|Jan 08, 2023
Phenotypic Characterization of Circulating Tumor Cells Isolated from Non-Small and Small Cell Lung Cancer Patients.

Argyro Roumeliotou, Evangelia Pantazaka, Anastasia Xagara

|Aug 26, 2022
PD-L1/pS6 in Circulating Tumor Cells (CTCs) during Osimertinib Treatment in Patients with Non-Small Cell Lung Cancer (NSCLC).

Evangelia Pantazaka, Aliki Ntzifa, Argyro Roumeliotou

|Apr 12, 2022
PARP-1 Expression and BRCA1 Mutations in Breast Cancer Patients' CTCs.

Thodoris Sklias, Vasileios Vardas, Evangelia Pantazaka

Pageof 2

Frequent Collaborators

5 joint publications

Athanasios Kotsakis

5 joint publications

Galatea Kallergi

4 joint publications

Vassilis Georgoulias

3 joint publications

Evi Lianidou